Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion

Overview of attention for article published in Kidney International, December 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 12 X users

patent: 6 patents

Readers on

mendeley: 168 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 6 patents that reference this research output.

Methods for treating complement-mediated diseases

Grant US-12686713-B2

United States of America

21 Jul 2026

Anti-C1S antibodies and methods of use thereof

Grant US-12391750-B2

United States of America

19 Aug 2025

Anti-complement C1s antibodies and uses thereof

Grant US-12240917-B2

United States of America

04 Mar 2025

Anti-complement C1s antibodies and uses thereof

Grant US-12215169-B2

United States of America

04 Feb 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.